A CROSSOVER COMPARISON OF NABILONE AND PROCHLORPERAZINE FOR EMESIS INDUCED BY CANCER-CHEMOTHERAPY

被引:37
作者
NIIRANEN, A
MATTSON, K
机构
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1985年 / 8卷 / 04期
关键词
D O I
10.1097/00000421-198508000-00013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:336 / 340
页数:5
相关论文
共 12 条
[1]   ANTI-EMETIC EFFICACY AND TOXICITY OF NABILONE, A SYNTHETIC CANNABINOID, IN LUNG-CANCER CHEMOTHERAPY [J].
AHMEDZAI, S ;
CARLYLE, DL ;
CALDER, IT ;
MORAN, F .
BRITISH JOURNAL OF CANCER, 1983, 48 (05) :657-663
[3]  
GRALLA RJ, 1984, CANCER TREAT REP, V68, P163
[4]  
HERMAN TS, 1977, BIOMED EXPRESS, V27, P331
[5]   2-PERIOD CROSSOVER CLINICAL-TRIAL [J].
HILLS, M ;
ARMITAGE, P .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (01) :7-20
[6]   A DOUBLE-BLIND, CONTROLLED TRIAL OF NABILONE VS PROCHLORPERAZINE FOR REFRACTORY EMESIS INDUCED BY CANCER-CHEMOTHERAPY [J].
JOHANSSON, R ;
KILKKU, P ;
GROENROOS, M .
CANCER TREATMENT REVIEWS, 1982, 9 :25-33
[7]   ANTI-EMETICS - A ROUND-TABLE DISCUSSION [J].
LASZLO, J ;
GRALLA, RJ ;
EINHORN, LH ;
WAMPLER, G .
DRUGS, 1983, 25 :74-80
[8]   PHARMACOKINETICS, METABOLISM AND DRUG-ABUSE POTENTIAL OF NABILONE [J].
LEMBERGER, L ;
RUBIN, A ;
WOLEN, R ;
DESANTE, K ;
ROWE, H ;
FORNEY, R ;
PENCE, P .
CANCER TREATMENT REVIEWS, 1982, 9 :17-23
[9]   DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .2. ANALYSIS AND EXAMPLES [J].
PETO, R ;
PIKE, MC ;
ARMITAGE, P ;
BRESLOW, NE ;
COX, DR ;
HOWARD, SV ;
MANTEL, N ;
MCPHERSON, K ;
PETO, J ;
SMITH, PG .
BRITISH JOURNAL OF CANCER, 1977, 35 (01) :1-39
[10]   ANTI-EMETICS IN PATIENTS RECEIVING CHEMOTHERAPY FOR CANCER - RANDOMIZED COMPARISON OF DELTA-9-TETRAHYDROCANNABINOL AND PROCHLORPERAZINE [J].
SALLAN, SE ;
CRONIN, C ;
ZELEN, M ;
ZINBERG, NE .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (03) :135-138